摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-di(methylthio)phenol | 13333-48-7

中文名称
——
中文别名
——
英文名称
2,4-di(methylthio)phenol
英文别名
2,4-Bisphenol;o,p-di(methylthio)phenol;2,4-dimethyl-thiophenol;2,4-dimethylthiophenol;2,4-Bis(methylthio)phenol;2,4-bis(methylsulfanyl)phenol
2,4-di(methylthio)phenol化学式
CAS
13333-48-7
化学式
C8H10OS2
mdl
——
分子量
186.299
InChiKey
ALTBDYBDBRPBGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    40-41 °C
  • 沸点:
    290.3±35.0 °C(Predicted)
  • 密度:
    1.26±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    70.8
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,5-dimethyl-2,6-bis(methylthio)phenol 、 2,4-di(methylthio)phenol 生成 3,5-dimethyl-2,4,6-tris(methylthio)phenol
    参考文献:
    名称:
    (Hydrocarbylthio)phenols and their preparation
    摘要:
    含有至少两个烃基硫基团的(烃基硫基)酚类化合物是通过在铝酚酸催化下,将酚类化合物与过量的烃基二硫化物反应制备而成。这种方法可以制备新颖且有用的含有至少两个烃基硫基团的(烃基硫基)酚类化合物。含有至少两个烃基硫基团的(烃基硫基)酚类化合物是有机材料的有效抗氧化剂,通常易于氧化恶化,例如矿物油。
    公开号:
    US04533753A1
  • 作为产物:
    参考文献:
    名称:
    RANKEN, P. F.
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Disubstituted xanthone carboxylic acid compounds
    申请人:Syntex (U.S.A.) Inc.
    公开号:US03963752A1
    公开(公告)日:1976-06-15
    Compositions containing and methods employing, as the essential ingredient, novel disubstituted xanthone carboxylic acid compounds which are useful in the treatment of allergic conditions. Methods for preparing these compounds and compositions and intermediates therein are also disclosed. 5-Methylsulfinyl-7-isopropoxyxanthone-2-carboxylic acid and 5,7-di(methylsulfinyl)xanthone-2-carboxylic acid are illustrated as representative compounds.
    含有和采用作为基本成分的新型二取代黄酮羧酸化合物的组合物和方法,这些化合物在治疗过敏症状方面很有用。还公开了制备这些化合物、组合物和中间体的方法。5-甲基亚砜基-7-异丙氧基黄酮-2-羧酸和5,7-二(甲基亚砜基)黄酮-2-羧酸被作为代表性化合物进行了说明。
  • Method of use of, and compositions containing, disubstituted xanthone
    申请人:Syntex (U.S.A.) Inc.
    公开号:US03951618A1
    公开(公告)日:1976-04-20
    Compositions containing and methods employing, as the essential ingredient, novel disubstituted xanthone carboxylic acid compounds which are useful in the treatment of allergic conditions. Methods for preparing these compounds and compositions and intermediates therein are also disclosed. 5-Methylthio-7-isopropoxyxanthone-2-carboxylic acid and 5,7-di-(methylthio)xanthone-2-carboxylic acid are illustrated as representative compounds.
    包含和使用新型二取代黄酮羧酸化合物作为主要成分的组合物和方法,这些化合物对治疗过敏症状有用。还公开了制备这些化合物、组合物和其中间体的方法。以5-甲硫基-7-异丙氧基黄酮-2-羧酸和5,7-二-(甲硫基)黄酮-2-羧酸作为代表性化合物。
  • 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles
    申请人:Tsubouchi Hidetsugu
    公开号:US20060094767A1
    公开(公告)日:2006-05-04
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R 1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R 2 represents a group —OR 3 or the like, and R 3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R 1 and —(CH 2 ) n R 2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R 41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.
    本发明提供了一种2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物,其通式如下:其中,R1代表氢原子或C1-C6烷基,n代表0到6的整数,R2代表—OR3或类似的基团,R3代表氢原子、C1-C6烷基或类似的基团,或者R1和—(CH2)nR2可以通过相邻的碳原子通过氮原子结合在一起形成一个螺环,其通式为(H):其中,R41为氢、C1-C6烷基或类似的基团。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型酸性快速细菌具有优异的杀菌作用。
  • 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP1555267A1
    公开(公告)日:2005-07-20
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group -OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and a typical acid-fast bacteria.
    本发明提供了由以下通式代表的 2,3-二氢-6-硝基咪唑并[2,1-b]恶唑化合物: 其中R1代表氢原子或C1-C6烷基,n代表0至6的整数,R2代表基团-OR3或类似基团,R3代表氢原子、C1-C6烷基或类似基团,或者R1和-(CH2)nR2可以通过氮原子与相邻的碳原子相互结合,从而形成通式(H)代表的螺环: 其中 R41 为氢、C1-C6 烷基或类似基团。本化合物对结核分枝杆菌、多重耐药结核分枝杆菌和典型的耐酸细菌有很好的杀菌作用。
  • 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP2570418A2
    公开(公告)日:2013-03-20
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group -OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.
    本发明提供了一种由以下通式表示的 2,3-二氢-6-硝基咪唑并[2,1-b]恶唑化合物: 其中R1代表氢原子或C1-C6烷基,n代表0至6的整数,R2代表基团-OR3或类似基团,R3代表氢原子、C1-C6烷基或类似基团,或者R1和-(CH2)nR2可以通过氮原子与相邻的碳原子相互结合,从而形成通式(H)代表的螺环: 其中 R41 为氢、C1-C6 烷基或类似基团。本化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型耐酸菌有很好的杀菌作用。
查看更多